Abstract
For patients without symptoms and at risk, there is no established early detection program to discover carcinomas of the upper aerodigestive tract in the sense of secondary prevention. Such type of prevention seems even more desirable because the chances for a cure and the quality of life are strongly dependent on the stage of the tumor and the time of the initial diagnosis. Six hundred and eight patients without symptoms but at least one of the self-reported risk factors “smoking”, “alcohol consumption” or “reflux” were examined with an endoscope or an optical microscope for pathological findings in the upper aerodigestive tract once a year. In addition, the incidence of malignancies of the upper aerodigestive tract between 2001 and 2010 was determined through the Cancer Registry of Schleswig–Holstein. Tissue samples were taken from 18 of the 608 patients. Eleven patients (1.8 %) had a squamous cell carcinoma. Another patient suffered from non-Hodgkin’s lymphoma and one from larynx tuberculosis. The ratio of detected malignancies in the oral cavity and the oropharynx on the one hand and the hypopharynx and larynx, which can only be examined by endoscopes, on the other hand were in our cohorts and in our survey according to the cancer registry was 5/6. The above-described methods allow examining risk patients easily and safely. According to current publications, the ratio of the found malignancies exceeds the expected ratio significantly, which presumably was caused by the examination targeting patients at risk. Due to the expanded examination area using optical instruments more than doubles the rate of discoverable malignancies compared to the limitations posed by the examination of directly visible areas of the oral cavity of the oropharynx.
Similar content being viewed by others
References
Husmann G, Kaatsch P, Katalinic A, Bertz J, Haberland J, Kraywinkel K, Wolf U (2010) Krebs in Deutschland, 2005/2006, Häufigkeiten und Trends. 7th edn. Beiträge zur Gesundheitsberichtserstattung des Bundes. Eine gemeinsame Veröffentlichung des Robert Koch-Institutes und der Gesellschaft der epidemiologischen Krebsregister in Deutschland e. V
Spitz MR (1994) Epidemiology and risk factors for head and neck cancer. Semin Oncol 21(3):281–288
Knecht R (2009) Strahlen-, Chemo- und Target-Therapie von Kopf-Hals-Karzinomen-Neue Entwicklungen. HNO 57:436–445
Hoffmann HAT, Karnell LH, Shah JP, Aryan S, Brown GS, Fee WE, Glass AG, Goepfert H, Ossof RH, Fremgen AM (1997) Hypopharyngeal cancer patient care evaluation. Laryngoscope 107:1005–1017
Zhou I, Cheg I, Tao L, Jia X, Lu Y, Liao P (2006) Detection of hypopharyngeal squamous cell carcinoma using serum proteomics. Acta Otolaryngol 126:853–860
Eckel HE, Staar S, Volling P, Sittel C, Damm M, Jungehuelsing M (2001) Surgical treatment for hypopharynx carcinoma: feasibility, mortality, and results. Otolaryngol Head Neck Surg 124:561–569
Prince A, Aguirre-Ghizo J, Genden E, Posner M, Sikora A (2010) Head and neck squamous cell carcinoma: new translational therapies. Mt Sinai J Med 77(6):684–699. doi:10.1002/msj.20216
Marcus KJ, Tishler RB (2010) Head and neck carcinomas across the age spectrum: epidemiology, therapy, and late effects. Semin Radiat Oncol 20(1):52–57
Gerstner AOH (2008) Früherkennung von Kopf-Hals-Tumoren. Entwicklung, aktueller Stand und Perspektiven. Otorhinolaryngol 87:S1–S20
Leemans CR, Braakhuis BJ, Brakenhoff RH (2010) The molecular biology of head and neck cancer. Nat Rev Cancer. doi:10.1038/nrc2982
Charles LE, Burchfiel CM, Fekedulegn D, Gu JK, Petrovitch H, Sanderson WT, Masaki K, Rodriguez BL, Andrew ME, Ross GW (2010) Occupational exposure to pesticides, metals, and solvents: the impact on mortality rates in the Honolulu Heart Program. Work 37(2):205–215
Bhatti P, Newcomer L, Onstad L, Teschke K, Camp J, Morgan M, Vaughan TL (2010) Wood dust exposure and risk of lung cancer. Occup Environ Med. doi:10.1136/oem.2010.060004
Zhong Y, Carmella SG, Hochalter JB, Balbo S, Hecht SS (2010) Analysis of r-7, t-8,9, c-10-Tetrahydroxy-7,8,9,10-tetrahydrobenzo[a]pyrene in human urine: a biomarker for directly assessing carcinogenic polycyclic aromatic hydrocarbon exposure plus metabolic activation. Chem Res Toxicol. doi:10.1021/tx100287n
Brusis T (2012) Aus der Gutachtenpraxis: Larynxkarzinom durch intensive und mehrjährige Exposition gegenüber schwefelsäurehaltigen Aerosolen. Laryngo Rhino Otol 91:323–325
Hertrampf K, Wiltfang J, Katalinic A, Timm O, Wenz HJ (2012) Trends in incidence, tumour sites ad tumour stages of oral and pharyngea cancer in Northern Germany. J Cancer Res Clin Oncol 138:431–437
Sackett DL (2002) The arrogance of preventive medicine. CMAJ 167:263–264
Mühlhauser I (2007) Ist vorbeugen besser als heilen? Dtsch Arztebl 104:A1804–A1807
Kujan O, Glenny AM, Oliver RJ, Thakker N, Sloan P (2006) Screening programmes for the early detection and prevention of oral cancer. Cochrane database of systematic reviews 3: Art. No.: CD004150. doi:10.1002/14651858.CD004150.pub2
Mihailescu D, Shore-Freedman E, Mukami S, Lubin J, Ron E, Scheider AB (2002) Multiple neoplasms in an irradiated cohort: pattern of occurrence and relationship to thyroid cancer outcome. J Colin Endocrinol Metab 87:3236–3241
Gao X, Fisher SG, Mohidee N, Emami B (2003) Second primary cancers in patients with laryngeal caner: a population-based study. Int J Radio Oncol Biol Phys 56:427–435
Martin G, Glanz H, Kleinsasser O (1979) Ionisiernde Strahlen und Kehlkopfkrebse. Laryngo Rhino Otol 58:187–195
Scherübl H, Steinberg J, Schwertner C, Mir-Salim P, Stölzel U, de Villiers EM (2007) “Field cancerization”im oberen Aerodigestrivtrakt–Überwachungsempfehlungen für Risikopersonen. HNO 56:603–608
http://www.krebsregister-sh.de/datenbank. Accessed 10 April 2013
Joseph AW, D’Souza G (2012) Epidemiology of human papillomavirus-related head and neck cancer. Otolaryngol Clin North Am 45:739–764
https://www.destatis.de/DE/ZahlenFakten/GesellschaftStaat/Gesundheit/GesundheitszustandRelevantesVerhalten/Tabellen/Rauchverhalten.html. Accessed 10 April 2013
Barnes L, Eveson JW, Reichart P, Sidransky D (Hrg) (2005) WHO Classification of Tumours: pathology and genetics of head and neck tumours. vol 9. IARC-Press, Lyon, France
Ambrosch P (1996) Screeninguntersuchungen zur Früherkennung von Karzinomen der oberen Luft- und Speisewege. HNO 44:609–611
Gemeinsamer Bundesausschuss (2007) http://www.g-ba.de/downloads/40-268-416/2007-05-30-Abschlu%C3%9F_verpfl-Frueherkennung.pdf
Watanabe A, Hossokawa M, Taniguchi M, Sasaki S (2003) Periodic pharyngolaryngoscopy detects early head and neck cancer and improves survival in esophageal cancer. Ann Thorac Surg 76:1699–1705
Möschler O, Spahn TW, Middelberg-Bisping C, Grosse-Thie W, Christoph B, Kloeppel G, Mueller MK (2006) Chromoendoscopy is a valuable tool for screening of high-risk patients with head and neck cancer for early detection of esophageal cancer. Digestion 73:160–166
Fritzsche K, Breitenstein K, Esser D (2010) Patienten mit Malignomen des Oro- und Hypopharynx sowie Larynx-Stellenwert der onkologischen Nachsorgesprechstunde. HNO 58:756–761
Bootz F, Howaldt HP (2006) Karzinome des oberen Aerodigestivtrraktes. In: Kurzgefasste interdisziplinäre Leitlinien 2006. Deutsche Krebsgesellschaft. Zuckscherdt Verlag, pp 31–50
McLeod NMH, Saeed SNR, Ali EA (2005) Delays in referral and diagnosis persist. Br Dent J 198:681–684
Mignoma MD, Fedele S, Lo Russo L, Ruoppo E, Lo Muzio L (2001) Oral and pharyngeal cancer: lack of prevention and early detection by health care providers. Eur J Cancer Prev 10:381–383
Hertrampf K (2009) Projekt zur Tumorfrüherkennung im Norden. Nordlicht 13(6):22–23, 13(7): 32–33
Festinger L (1957) A theory of cognitive dissonance. Row, Peterson, Evanston
Brehm JW (1959) Increasing cognitive dissonance by a fait accompli. J Abnorm Psychol 58:379–382
Case DO, Andrews JE, Johnson JD, Allard SL (2005) Avoiding versus seeking: the relationship of information seeking to avoidance, blunting, coping, dissonance, and related concepts. J Med Libr Assoc 93:353–362
Lessels AM, Burnett RA, Goodlad RJ et al (2000) Comment on a recent paper and editorial on the subject of dysplasia classification. J Pathol 198:131–132
Steiner W (1985) Krebsvorsorge und –früherkennungsuntersuchungen der oberen Luft- und Speisewege bei Risikogruppen. Kohlhammer, Stuttgart
Steiner W, Ambrosch P, Aurbach G (1991)Vorsorge und Früherkennung von Plattenepithelkarzinomen des oberen Aerodigestrivtraktes. In: Maier H, Weidauer H Krebsrisiken im Kopf-Hals-Bereich. Springer, Berlin Heidelberg, New York
Ambrosch P (2011) personally report
Ambrosch P (2007) The role of laser microsurgery in treatment of laryngeal cancer. Curr Opin Otolaryngol Head Neck Surg 15:82–88
Eckel HE, Schröder U, Jungehülsing M, Guntinas-Lichius O, Markitz M, Raunik W (2008) Indikationen zur chirurgischen Therapie von Larynx- und Hypopharynxkarzinomen. Wiener Med Wochenschr 158:255–263
Preuss SF, Cramer K, Drebber U, Klussmann JP, Eckel HE, Guntinas-Lichius O (2008) Second-look microlaryngoscopy to detect residual carcinoma in patients after laser surgery for T1 and T2 laryngeal cancer. Acta Otolaryngol 16:1–5
Dietz A, Rudat V, Dreyhaupt J, Pritsch M, Hoppe F, Hagen R, Pfreundner L, Schröder U, Eckel H, Hess M, Schröder M, Schneider P, Jens B, Zenner HP, Werner JA, Engenhardt-Cabillic R, Vanselow B, Plinkert P, Niewald M, Kuhnt T, Budach W, Flentje M (2009) Induction chemotherapy with paclitaxel and cisplatin followed by radiotherapy for larynx organ preservation in advanced laryngeal and hypopharyngeal cancer offers moderate late toxicity outcome (DeLOS-I-trial). Eur Arch Otolaryngol 266:1291–1300
Kesselring R, Thiel A, Pries R, Trenkle T, Wollenberg B (2010) Human Th17 cells can be induced through head and neck cancer and have a functional impact on HNSCC development. Br J Cancer 103:1245–1254
Papaspyrou G, Werner JA, Dietz A (2011) Pharmacotherapy for squamous-cell carcinoma of the head and neck. Expert Opin Pharmacother 12:397–412
Volgger V, Stepp H, Jerjes W, Upile T, Leunig A, Hopper C, Betz (2010) Current Munich status concerning in vivo optical coherence tomography for differentiating lesions of the upper aerodigestive tract. Head Neck Oncol 2(Suppl 1):O39
Upile T, Jerjes WK, Sterenborg HJ, Wong BJ, El-Naggar AK, Ilgner JF, Sandison A, Witjes MJ, Biel MA, van Veen R, Hamdoon Z, Gillenwater A, Mosse CA, Robinson DJ, Betz CS, Stepp H, Bolotine L, McKenzie G, Barr H, Chen Z, Berg K, D’Cruz AK, Sudhoff H, Stone N, Kendall C, Fisher S, MacRobert AJ, Leunig A, Olivo M, Richards-Kortum R, Soo KC, Bagnato V, Choo-Smith LP, Svanberg K, Tan IB, Wilson BC, Wolfsen H, Bigio I, Yodh AG, Hopper C (2011) At the frontiers of surgery: review. Head Neck Oncol 3:7
Acknowledgments
At first, we would like to thank Mrs Prof. Dr. P. Ambrosch, Kiel, for her critically support of this study. We like to thank our colleagues Doctores H. Heinritz, Alzey, A. and G. Fryen, Verden, N. Holstein and A. Lingg, Karlsruhe-Durlach, J. Kleeberg, Rendsburg, W. Langhoff, Betzdorf, G.Rösch and A. Hanisch, Braunschweig, E. Schneeberg, Bruchsal, D. Heinrich and C. Reeh, Hamburg, for the support they provided us in the collection of data. At least we would like to extend a special thanks to Mrs B. Akcicek from the Research Institute for Applied Otolaryngology, of the German Professional Association of Otolaryngologists, Germany (WIAHNO, Wissenschaftliches Institut für angewandte HNO-Heilkunde, Deutscher Berufsverband der HNO-Ärzte e. V.) for preparing and revising the data and the research at the Schleswig–Holstein Cancer Registry.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Löhler, J., Gerstner, A.O.H., Bootz, F. et al. Incidence and localization of abnormal mucosa findings in patients consulting ENT outpatient clinics and data analysis of a cancer registry. Eur Arch Otorhinolaryngol 271, 1289–1297 (2014). https://doi.org/10.1007/s00405-013-2738-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-013-2738-z